Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease

Author： Riccioni Graziano   Cipollone Francesco   Santovito Donato   Scotti Luca   D'Orazio Nicolantonio   Mezzetti Andrea   Bucciarelli Tonino  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.17, 2011-12, pp. : 2599-2604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study

By Riccioni Graziano   Bazzano Lydia A   Bucciarelli Tonino   Mancini Barbara   Ilio Emanuela di   D'Orazio Nicolantonio  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 14, 2008-10 ,pp. : 2403-2408

Informa Healthcare

Access to resources Recommend Favorite

Common Carotid Artery Intima-media Thickness is not Increased but Distensibility is Reduced in Normotensive Patients with Type 2 Diabetes compared with Control Subjects

By Charvat J   Chlumsky J   Zakovicova E   Kvapil M  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 860-869

Field House Publishing

Access to resources Recommend Favorite

Intima-Media Thickness Measurements in the Carotid and Femoral Artery as an Indicator of Symptomatic Coronary Atherosclerosis

By  

Heart Drug, Vol. 1, Iss. 5, 2002-01 ,pp. : 249-254

Karger

Access to resources Recommend Favorite

Carotid Intima-Media Thickness: A Predictor of Response to Cholinesterase Inhibitors in Alzheimer's Disease?

By Saleh DrChristian  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 801-803

Adis International

Access to resources Recommend Favorite

Carotid Intima-Media Thickness as a Predictor of Response to Cholinesterase Inhibitors in Alzheimer's Disease: An Open-Label Trial

By Modrego Pedro J.  

CNS Drugs, Vol. 23, Iss. 3, 2009-01 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite